PT - JOURNAL ARTICLE AU - Chiziba, Chilochibi AU - Silal, Sheetal TI - Exploring measures to increase detection of malaria cases through reactive case detection in a Southern Province of Zambia-like Setup: A modelling study AID - 10.1101/2024.07.18.24310660 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.18.24310660 4099 - http://medrxiv.org/content/early/2024/07/19/2024.07.18.24310660.short 4100 - http://medrxiv.org/content/early/2024/07/19/2024.07.18.24310660.full AB - Introduction In Zambia, malaria prevalence varies spatially, posing challenges for intervention strategies. Asymptomatic and clinical carriers not accessing healthcare further complicate efforts, necessitating reactive case detection (RCD) to target undetected infections. However, operational hurdles, such as resource shortages and logistical complexities—including shortages of community health workers (CHWs), difficulties reaching residents, and limitations in malaria rapid diagnostic tests (RDTs)—hinder RCD’s effectiveness. Identifying effective improvement measures given circumstances that may lead to deficient intervention outcomes may improve the situation.Methods A mathematical model of malaria transmission conforming to Zambia’s low transmission areas defined as areas with an incidence of fewer than 200 malaria cases per 1,000 population per year was developed to simulate RCD using parameters and data from published articles. We explored the impact of literature-identified challenges on RCD performance in malaria detection and potential strategies to enhance detection rates. The examined factors and improvement measures included increasing CHWs, adjusting reaction time, RDT sensitivity, and implementing focal mass drug administration (fMDA).Results Simulation findings suggest that a shortage of CHWs and limited availability of RDTs have the highest negative impact on RCD compared to other challenges. In scenarios where CHWs or RDT availability for RCD were reduced by 50%, annual malaria cases were predicted to increase by approximately 17%. Only the incorporation of fMDA as an improvement measure succeeded in countering the situation. Increasing CHWs to offset RCD inefficiencies caused by limited RDT sensitivity or difficulties in finding individuals resulted in fewer cases than improving reaction time or increasing the screening radius.Conclusions Participation of CHWs is voluntary and primarily motivated by informal incentives, often provided by donors. Finding sustainable means to ensure the sufficient availability of CHWs may guarantee continued RCD contributions towards maintaining stable malaria prevalence and elimination. More research is required to explore the application of RCD in archetypical transmission areas suitable for RCD as improvement measures to the identified challenges hindering RCD. Furthermore, archetype-based targeting of interventions, including RCD, may also be explored to inform the optimisation of intervention resource allocation to overcome the widening gap in malaria funding.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [Grant Number INV 047-048]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript